Schubert Steffen, Rothe Diana, Werk Denise, Grunert Hans-Peter, Zeichhardt Heinz, Erdmann Volker A, Kurreck Jens
Institute for Chemistry and Biochemistry, Free University Berlin, Thielallee 63, D-14195 Berlin, Germany.
Antiviral Res. 2007 Mar;73(3):197-205. doi: 10.1016/j.antiviral.2006.10.005. Epub 2006 Nov 2.
RNA interference triggered by small interfering RNAs (siRNAs) can be used to effectively contain viral spread. Here, we report on the mechanism of action of siRNAs targeting the medically important coxsackievirus B3 (CVB-3) as a typical representative of viruses with a non-segmented RNA genome in positive-strand orientation. Antiviral siRNAs can be designed to target the genomic (+)-strand, the (-)-strand that occurs as a replication intermediate, or both. In the present study, two complementary and systematic approaches are presented providing direct evidence that silencing of the viral (+)-strand is the key to inhibit CVB-3: first, we used rational siRNA design to direct silencing activity specifically against either of the two viral strands. As a second approach, we employed siRNA containing modified nucleotides to render them specific for one of the virus RNAs. Experiments with infectious coxsackievirus revealed that the inhibitory efficiency correlates exclusively with the activity of the siRNAs directed against the viral (+)-strand. Our finding that only (+)-strand specific siRNAs exert significant antiviral potency may hold true for other RNA viruses with (+)-stranded genomes as well and may therefore be helpful in the development of efficient strategies to inhibit virus propagation.
由小干扰RNA(siRNA)引发的RNA干扰可用于有效抑制病毒传播。在此,我们报告了靶向医学上重要的柯萨奇病毒B3(CVB - 3)的siRNA的作用机制,CVB - 3是正链方向的非分段RNA基因组病毒的典型代表。抗病毒siRNA可设计靶向基因组(+)链、作为复制中间体出现的(-)链或两者。在本研究中,我们提出了两种互补且系统的方法,提供了直接证据表明沉默病毒(+)链是抑制CVB - 3的关键:首先,我们使用合理的siRNA设计将沉默活性特异性地导向两条病毒链中的任意一条。作为第二种方法,我们使用含有修饰核苷酸的siRNA使其对病毒RNA之一具有特异性。对感染性柯萨奇病毒的实验表明,抑制效率仅与针对病毒(+)链的siRNA的活性相关。我们的发现,即只有(+)链特异性siRNA具有显著的抗病毒效力,对于其他具有(+)链基因组的RNA病毒可能也适用,因此可能有助于开发抑制病毒传播的有效策略。